Skip to content

Lightpath Technologies LPTH Proceeds From Issuance Of Preferred Stock And Debt

Proceeds From Issuance Of Preferred Stock And Debt at other companies

Evommune
 logo
Evommune EVMN
$2M
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$26.55M
Evommune
 logo
Evommune EVMN
$2M
Peapack-Gladstone Financial logo
Peapack-Gladstone FinancialPGC
$30M
LBR
LB Pharmaceuticals Inc Common StockLBRX
$0-100%
Asset Entities logo
Asset EntitiesASST
$129.8M

Other financials

Income statement

See full
Revenue$19.1M+109%
Gross profit$4.5M+57.6%
Operating income-$2.5M-82.0%
Net income-$4.1M-14.6%
EPS (diluted)-$0.07-75.0%

Balance sheet

See full
Cash & equivalents$55.2M+753%
Total debt$11.4M-20.7%
Total equity$89.1M+467%
Total assets$144.3M+77.2%

Cash flow

See full
Operating cash flow-$6.8M-110%
CapEx$899.5K+114%
Free cash flow-$7.7M-110%

Valuation

See full
Market cap$855.82M+548%
Enterprise value$811.96M+480%
P/S13.6×+9.7×

Profitability

See full
Gross margin26.8%-1.7pp
Operating margin-29.5%+6.9pp
Net margin-37.4%+11.5pp
FCF margin-16.4%-2.1pp

Returns & leverage

See full
Return on equity-44.8%+2.1pp
Debt / equity0.1×-0.8×
Current ratio3.9×+1.6×

Where this comes from

Reported directly by Lightpath Technologies in its filing.

Tagged under the XBRL concept lpth:ProceedsFromIssuanceOfPreferredStockAndDebt.

The official record: Lightpath Technologies’s 10-K, filed September 26, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lightpath Technologies's proceeds from issuance of preferred stock and debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lightpath Technologies's proceeds from issuance of preferred stock and debt?
Lightpath Technologies (LPTH) reported proceeds from issuance of preferred stock and debt of $8.05M in Q2 2025.
What does proceeds from issuance of preferred stock and debt mean?
The combined cash proceeds received from the issuance of both preferred equity and debt instruments. This metric provides insight into the company's total capital raising activity through non-common equity instruments to support liquidity or growth initiatives.